Register Now - Beyond Recruitment: The Future of Patient Site Engagement in Oncology Clinical Trials
|Articles|July 30, 2013

CRF Health Improves Patient and Site eCOA Experience

CRF Health, the leading electronic Clinical Outcome Assessment (eCOA) solutions provider announced several innovative enhancements to their TrialMax eCOA solutions.

CRF Health, the leading electronic Clinical Outcome Assessment (eCOA) solutions provider announced several innovative enhancements to their TrialMax eCOA solutions.

CRF Health has added new usability and patient retention enhancements that improve the efficiency of collecting clinical outcome data directly from patients and sites.

Among the improved features:

  • Patient and site user experience improvements through meticulous user interface design and extensive usability testing, further reducing patient and site burden
  • Investigators have on-demand access to study specific training directly on the TrialMax Slate, improving site compliance by ensuring training is available when needed as a reference or for new staff supporting the trial
  • Ability to send SMS and email reminders to patients across all TrialMax eCOA solutions to keep patients engaged
  • The new TrialMax Slate study dashboard clearly displays the questionnaire status of all patient visits. This enhancement reduces site burden and increases the efficiency of the eCOA collection process by highlighting required and incomplete questionnaires

For more information on the enhancements to TrialMax eCOA solutions or on how CRF Health supports clinical trials by fitting into patients’ lives, visit their website (

www.crfhealth.com

).


Related to this article

Closing the Community Access Gap: Q&A with Kent Thoelke, Paradigm Health
In this Q&A, Kent Thoelke, CEO of Paradigm Health, discusses why participation gaps in community and rural settings come down to both patient cost barriers and site infrastructure, how legacy workflows weigh on community clinics, and what policy and technology changes it would take to make clinical research a real care option for more patients.
© Grispb - © Grispb - stock.adobe.com
Mistral and OpenAI produced identical overall eligibility labels across 200 synthetic patient-study assessments, with criterion-level disagreements concentrated in inclusion criteria where models switch between “Uncertain” and “Not included” when records lack sufficient evidence, so model choice should be driven by deployment architecture, control, and cost rather than assumed interchangeability.
The Human Side of Clinical Trials: Before Burden Becomes Risk, Capturing Friction in Real Time
In Episode 4 of The Human Side of Clinical Trials, host Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., speaks with Jason Riis, PhD, CEO and chief behavioral scientist at Behavioralize, about how capturing friction closer to the moment it happens can reveal unclear instructions, technology friction, and workarounds that retrospective surveys and debriefs tend to miss.